SK13142003A3 - Core-glycosylated HCV envelope proteins - Google Patents

Info

Publication number

SK13142003A3

SK13142003A3 SK1314-2003A SK13142003A SK13142003A3 SK 13142003 A3 SK13142003 A3 SK 13142003A3 SK 13142003 A SK13142003 A SK 13142003A SK 13142003 A3 SK13142003 A3 SK 13142003A3

Authority

SK

Slovakia

Prior art keywords

hcv

protein

coat protein

proteins

seq

Prior art date

2001-04-24

Links

• Espacenet
• Global Dossier
• Discuss

• 101710091045 Envelope protein Proteins 0.000 title claims abstract description 51
• 101710188315 Protein X Proteins 0.000 title claims abstract description 51
• 102100021696 Syncytin-1 Human genes 0.000 title claims abstract 8
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 248
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 243
• 210000004027 cell Anatomy 0.000 claims abstract description 80
• 238000000034 method Methods 0.000 claims abstract description 76
• 230000014509 gene expression Effects 0.000 claims abstract description 75
• 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 69
• 241000235648 Pichia Species 0.000 claims abstract description 64
• 108010014251 Muramidase Proteins 0.000 claims abstract description 21
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 21
• 239000004325 lysozyme Substances 0.000 claims abstract description 21
• 229960000274 lysozyme Drugs 0.000 claims abstract description 21
• 235000010335 lysozyme Nutrition 0.000 claims abstract description 21
• 210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 16
• 210000005253 yeast cell Anatomy 0.000 claims abstract description 10
• 102000016943 Muramidase Human genes 0.000 claims abstract 6
• 235000018102 proteins Nutrition 0.000 claims description 232
• 101710132601 Capsid protein Proteins 0.000 claims description 134
• 101710094648 Coat protein Proteins 0.000 claims description 129
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 129
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 129
• 101710125418 Major capsid protein Proteins 0.000 claims description 129
• 101710141454 Nucleoprotein Proteins 0.000 claims description 129
• 101710083689 Probable capsid protein Proteins 0.000 claims description 129
• 239000012634 fragment Substances 0.000 claims description 95
• 238000006206 glycosylation reaction Methods 0.000 claims description 94
• 230000013595 glycosylation Effects 0.000 claims description 92
• 239000000203 mixture Substances 0.000 claims description 82
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 68
• 241000282414 Homo sapiens Species 0.000 claims description 60
• 230000004988 N-glycosylation Effects 0.000 claims description 53
• 239000002245 particle Substances 0.000 claims description 48
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 47
• 229960005486 vaccine Drugs 0.000 claims description 30
• 241000124008 Mammalia Species 0.000 claims description 29
• 239000002671 adjuvant Substances 0.000 claims description 25
• 241000282693 Cercopithecidae Species 0.000 claims description 19
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 18
• 239000007787 solid Substances 0.000 claims description 18
• 239000003814 drug Substances 0.000 claims description 15
• 230000001939 inductive effect Effects 0.000 claims description 15
• 239000008194 pharmaceutical composition Substances 0.000 claims description 13
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 11
• 230000000890 antigenic effect Effects 0.000 claims description 11
• 230000002163 immunogen Effects 0.000 claims description 11
• 230000001225 therapeutic effect Effects 0.000 claims description 11
• 230000028993 immune response Effects 0.000 claims description 9
• 230000000069 prophylactic effect Effects 0.000 claims description 9
• 230000002860 competitive effect Effects 0.000 claims description 8
• 239000000178 monomer Substances 0.000 claims description 8
• DJQYYYCQOZMCRC-UHFFFAOYSA-N 2-aminopropane-1,3-dithiol Chemical group SCC(N)CS DJQYYYCQOZMCRC-UHFFFAOYSA-N 0.000 claims description 6
• 238000009007 Diagnostic Kit Methods 0.000 claims description 5
• 239000003937 drug carrier Substances 0.000 claims description 5
• OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 claims description 2
• JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 claims description 2
• NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 claims description 2
• NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 claims description 2
• 108010068380 arginylarginine Proteins 0.000 claims description 2
• 108010062796 arginyllysine Proteins 0.000 claims description 2
• 230000003915 cell function Effects 0.000 claims description 2
• 238000010668 complexation reaction Methods 0.000 claims description 2
• 108010054155 lysyllysine Proteins 0.000 claims description 2
• 125000005842 heteroatom Chemical group 0.000 claims 1
• 150000002704 mannoses Chemical class 0.000 claims 1
• 239000013598 vector Substances 0.000 abstract description 72
• 241000235070 Saccharomyces Species 0.000 abstract description 29
• 108091026890 Coding region Proteins 0.000 abstract description 12
• 241000271566 Aves Species 0.000 abstract 3
• 241000711549 Hepacivirus C Species 0.000 description 285
• 229920001542 oligosaccharide Polymers 0.000 description 86
• 239000000047 product Substances 0.000 description 85
• 235000001014 amino acid Nutrition 0.000 description 79
• 229940024606 amino acid Drugs 0.000 description 76
• 150000002482 oligosaccharides Chemical class 0.000 description 71
• 108700008783 Hepatitis C virus E1 Proteins 0.000 description 69
• 150000001413 amino acids Chemical class 0.000 description 69
• 239000013612 plasmid Substances 0.000 description 60
• 239000000523 sample Substances 0.000 description 58
• 238000003776 cleavage reaction Methods 0.000 description 54
• 230000007017 scission Effects 0.000 description 54
• 241000320412 Ogataea angusta Species 0.000 description 52
• 238000011534 incubation Methods 0.000 description 50
• 108020004414 DNA Proteins 0.000 description 49
• 102000053602 DNA Human genes 0.000 description 48
• 210000004962 mammalian cell Anatomy 0.000 description 45
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 44
• 238000010828 elution Methods 0.000 description 43
• PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 42
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 42
• OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 41
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 41
• 238000011282 treatment Methods 0.000 description 41
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 39
• 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 37
• 102000001696 Mannosidases Human genes 0.000 description 36
• 108010054377 Mannosidases Proteins 0.000 description 36
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
• 239000000427 antigen Substances 0.000 description 32
• 108091007433 antigens Proteins 0.000 description 31
• 102000036639 antigens Human genes 0.000 description 31
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 31
• 238000006243 chemical reaction Methods 0.000 description 30
• 108020004705 Codon Proteins 0.000 description 29
• 238000000746 purification Methods 0.000 description 29
• 230000009257 reactivity Effects 0.000 description 29
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 28
• 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 description 28
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 27
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 27
• 235000000346 sugar Nutrition 0.000 description 27
• 238000002360 preparation method Methods 0.000 description 26
• 210000002966 serum Anatomy 0.000 description 26
• 238000001262 western blot Methods 0.000 description 25
• DINOPBPYOCMGGD-VEDJBHDQSA-N Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 DINOPBPYOCMGGD-VEDJBHDQSA-N 0.000 description 24
• 241000700618 Vaccinia virus Species 0.000 description 23
• 239000000872 buffer Substances 0.000 description 23
• 150000007523 nucleic acids Chemical class 0.000 description 23
• 230000002441 reversible effect Effects 0.000 description 23
• 239000002904 solvent Substances 0.000 description 23
• 238000002965 ELISA Methods 0.000 description 22
• 241000588724 Escherichia coli Species 0.000 description 22
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
• 238000002474 experimental method Methods 0.000 description 20
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
• QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 description 19
• 108010055059 beta-Mannosidase Proteins 0.000 description 19
• 150000002772 monosaccharides Chemical class 0.000 description 19
• 102100032487 Beta-mannosidase Human genes 0.000 description 18
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
• 238000004458 analytical method Methods 0.000 description 18
• 238000003556 assay Methods 0.000 description 18
• 150000001875 compounds Chemical class 0.000 description 18
• 239000000499 gel Substances 0.000 description 18
• KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 17
• KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 17
• 229960003237 betaine Drugs 0.000 description 17
• 239000003795 chemical substances by application Substances 0.000 description 17
• 238000010276 construction Methods 0.000 description 17
• 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 17
• 230000004048 modification Effects 0.000 description 17
• 238000012986 modification Methods 0.000 description 17
• 102000039446 nucleic acids Human genes 0.000 description 17
• 108020004707 nucleic acids Proteins 0.000 description 17
• 238000000926 separation method Methods 0.000 description 17
• 241000235058 Komagataella pastoris Species 0.000 description 16
• 102100033468 Lysozyme C Human genes 0.000 description 16
• 238000002835 absorbance Methods 0.000 description 16
• 238000004925 denaturation Methods 0.000 description 16
• 230000036425 denaturation Effects 0.000 description 16
• 238000000855 fermentation Methods 0.000 description 16
• 230000004151 fermentation Effects 0.000 description 16
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 16
• 229920001184 polypeptide Polymers 0.000 description 16
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 102000005744 Glycoside Hydrolases Human genes 0.000 description 15
• 108010031186 Glycoside Hydrolases Proteins 0.000 description 15
• 101710125507 Integrase/recombinase Proteins 0.000 description 15
• 108010012864 alpha-Mannosidase Proteins 0.000 description 15
• 102000019199 alpha-Mannosidase Human genes 0.000 description 15
• 230000002255 enzymatic effect Effects 0.000 description 15
• 239000000463 material Substances 0.000 description 15
• 210000004940 nucleus Anatomy 0.000 description 15
• 239000011541 reaction mixture Substances 0.000 description 15
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
• OSKIPPQETUTOMW-YHLOVPAPSA-N N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2R,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5R,6R)-6-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 OSKIPPQETUTOMW-YHLOVPAPSA-N 0.000 description 14
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 14
• 229960000723 ampicillin Drugs 0.000 description 14
• 239000013605 shuttle vector Substances 0.000 description 14
• 239000000126 substance Substances 0.000 description 14
• 108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 13
• 102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 13
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 13
• 235000018417 cysteine Nutrition 0.000 description 13
• 239000002773 nucleotide Substances 0.000 description 13
• 125000003729 nucleotide group Chemical group 0.000 description 13
• -1 nucleotide sugars Chemical class 0.000 description 13
• 102000035195 Peptidases Human genes 0.000 description 12
• 108091005804 Peptidases Proteins 0.000 description 12
• 206010046865 Vaccinia virus infection Diseases 0.000 description 12
• 230000029936 alkylation Effects 0.000 description 12
• 238000005804 alkylation reaction Methods 0.000 description 12
• 230000015572 biosynthetic process Effects 0.000 description 12
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 12
• 239000008103 glucose Substances 0.000 description 12
• 238000000338 in vitro Methods 0.000 description 12
• 230000006698 induction Effects 0.000 description 12
• DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 12
• 102000040430 polynucleotide Human genes 0.000 description 12
• 108091033319 polynucleotide Proteins 0.000 description 12
• 230000001603 reducing effect Effects 0.000 description 12
• 238000001542 size-exclusion chromatography Methods 0.000 description 12
• 238000010367 cloning Methods 0.000 description 11
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 11
• 208000015181 infectious disease Diseases 0.000 description 11
• 238000004519 manufacturing process Methods 0.000 description 11
• 239000008188 pellet Substances 0.000 description 11
• 239000002157 polynucleotide Substances 0.000 description 11
• 238000012163 sequencing technique Methods 0.000 description 11
• 238000006277 sulfonation reaction Methods 0.000 description 11
• 208000007089 vaccinia Diseases 0.000 description 11
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 10
• 102000003960 Ligases Human genes 0.000 description 10
• 108090000364 Ligases Proteins 0.000 description 10
• 229910019142 PO4 Inorganic materials 0.000 description 10
• 230000015556 catabolic process Effects 0.000 description 10
• 238000004113 cell culture Methods 0.000 description 10
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 10
• 238000006731 degradation reaction Methods 0.000 description 10
• 230000029087 digestion Effects 0.000 description 10
• 238000010790 dilution Methods 0.000 description 10
• 239000012895 dilution Substances 0.000 description 10
• 229960002897 heparin Drugs 0.000 description 10
• 229920000669 heparin Polymers 0.000 description 10
• 230000003053 immunization Effects 0.000 description 10
• 238000003018 immunoassay Methods 0.000 description 10
• 238000011081 inoculation Methods 0.000 description 10
• 230000014759 maintenance of location Effects 0.000 description 10
• 239000002609 medium Substances 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 238000002703 mutagenesis Methods 0.000 description 10
• 231100000350 mutagenesis Toxicity 0.000 description 10
• 238000012545 processing Methods 0.000 description 10
• 230000009467 reduction Effects 0.000 description 10
• 239000000243 solution Substances 0.000 description 10
• 238000006467 substitution reaction Methods 0.000 description 10
• 150000008163 sugars Chemical class 0.000 description 10
• 125000003396 thiol group Chemical group [H]S* 0.000 description 10
• 101800002780 Crustacean hyperglycemic hormone Proteins 0.000 description 9
• 241000699670 Mus sp. Species 0.000 description 9
• 108091028043 Nucleic acid sequence Proteins 0.000 description 9
• 239000011543 agarose gel Substances 0.000 description 9
• 230000001684 chronic effect Effects 0.000 description 9
• 230000000694 effects Effects 0.000 description 9
• 238000005227 gel permeation chromatography Methods 0.000 description 9
• 238000004128 high performance liquid chromatography Methods 0.000 description 9
• 238000002649 immunization Methods 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• 229920002477 rna polymer Polymers 0.000 description 9
• 238000012360 testing method Methods 0.000 description 9
• 102000012410 DNA Ligases Human genes 0.000 description 8
• 108010061982 DNA Ligases Proteins 0.000 description 8
• 102000004190 Enzymes Human genes 0.000 description 8
• 108090000790 Enzymes Proteins 0.000 description 8
• 101710144111 Non-structural protein 3 Proteins 0.000 description 8
• 241000282579 Pan Species 0.000 description 8
• 239000012505 Superdex™ Substances 0.000 description 8
• 230000000903 blocking effect Effects 0.000 description 8
• 210000004369 blood Anatomy 0.000 description 8
• 239000008280 blood Substances 0.000 description 8
• 239000007795 chemical reaction product Substances 0.000 description 8
• 238000002296 dynamic light scattering Methods 0.000 description 8
• 229940088598 enzyme Drugs 0.000 description 8
• 238000001976 enzyme digestion Methods 0.000 description 8
• 230000002427 irreversible effect Effects 0.000 description 8
• 210000004379 membrane Anatomy 0.000 description 8
• 229910052760 oxygen Inorganic materials 0.000 description 8
• 235000021317 phosphate Nutrition 0.000 description 8
• 230000008569 process Effects 0.000 description 8
• 108091008146 restriction endonucleases Proteins 0.000 description 8
• 230000004936 stimulating effect Effects 0.000 description 8
• 108010078791 Carrier Proteins Proteins 0.000 description 7
• 108010041986 DNA Vaccines Proteins 0.000 description 7
• 229940021995 DNA vaccine Drugs 0.000 description 7
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 7
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
• HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 7
• 108091034117 Oligonucleotide Proteins 0.000 description 7
• 241000700605 Viruses Species 0.000 description 7
• 230000003698 anagen phase Effects 0.000 description 7
• 235000014633 carbohydrates Nutrition 0.000 description 7
• 239000005018 casein Substances 0.000 description 7
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 7
• 235000021240 caseins Nutrition 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• 230000000295 complement effect Effects 0.000 description 7
• 238000000605 extraction Methods 0.000 description 7
• SHFKGANKURXVMY-LCWPZEQJSA-N hcv e2 protein Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)CC1=CC=CC=C1 SHFKGANKURXVMY-LCWPZEQJSA-N 0.000 description 7
• 238000002955 isolation Methods 0.000 description 7
• 125000005647 linker group Chemical group 0.000 description 7
• 239000001301 oxygen Substances 0.000 description 7
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
• 239000010452 phosphate Substances 0.000 description 7
• 150000003573 thiols Chemical class 0.000 description 7
• 238000002255 vaccination Methods 0.000 description 7
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• 208000002109 Argyria Diseases 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• 108010074860 Factor Xa Proteins 0.000 description 6
• 229920000057 Mannan Polymers 0.000 description 6
• GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 6
• 239000004365 Protease Substances 0.000 description 6
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 6
• 238000001042 affinity chromatography Methods 0.000 description 6
• 125000000539 amino acid group Chemical group 0.000 description 6
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
• 150000001720 carbohydrates Chemical class 0.000 description 6
• 238000005119 centrifugation Methods 0.000 description 6
• 201000010099 disease Diseases 0.000 description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
• 238000002347 injection Methods 0.000 description 6
• 239000007924 injection Substances 0.000 description 6
• 239000002502 liposome Substances 0.000 description 6
• 230000005012 migration Effects 0.000 description 6
• 238000013508 migration Methods 0.000 description 6
• 229910052757 nitrogen Inorganic materials 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 238000012216 screening Methods 0.000 description 6
• 229910052717 sulfur Inorganic materials 0.000 description 6
• 230000009466 transformation Effects 0.000 description 6
• 230000001131 transforming effect Effects 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• 108090001008 Avidin Proteins 0.000 description 5
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 5
• 108091000080 Phosphotransferase Proteins 0.000 description 5
• 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 5
• 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 5
• 108010076039 Polyproteins Proteins 0.000 description 5
• 229920002684 Sepharose Polymers 0.000 description 5
• 229930006000 Sucrose Natural products 0.000 description 5
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
• 238000005273 aeration Methods 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 125000000837 carbohydrate group Chemical group 0.000 description 5
• 229910052799 carbon Inorganic materials 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 239000007857 degradation product Substances 0.000 description 5
• 150000002019 disulfides Chemical class 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 238000001502 gel electrophoresis Methods 0.000 description 5
• 229910052736 halogen Inorganic materials 0.000 description 5
• 150000002367 halogens Chemical class 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 238000010829 isocratic elution Methods 0.000 description 5
• 238000002156 mixing Methods 0.000 description 5
• 238000012544 monitoring process Methods 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 102000020233 phosphotransferase Human genes 0.000 description 5
• 239000011734 sodium Substances 0.000 description 5
• 239000005720 sucrose Substances 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 239000003643 water by type Substances 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 239000004382 Amylase Substances 0.000 description 4
• 101710095342 Apolipoprotein B Proteins 0.000 description 4
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 4
• 102000007592 Apolipoproteins Human genes 0.000 description 4
• 108010071619 Apolipoproteins Proteins 0.000 description 4
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
• 244000062995 Cassia occidentalis Species 0.000 description 4
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
• 101150082674 E2 gene Proteins 0.000 description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
• 108700039791 Hepatitis C virus nucleocapsid Proteins 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
• 102000007330 LDL Lipoproteins Human genes 0.000 description 4
• 108010007622 LDL Lipoproteins Proteins 0.000 description 4
• 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 description 4
• 239000000020 Nitrocellulose Substances 0.000 description 4
• 101800001020 Non-structural protein 4A Proteins 0.000 description 4
• 101800001019 Non-structural protein 4B Proteins 0.000 description 4
• 101800001014 Non-structural protein 5A Proteins 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 239000002033 PVDF binder Substances 0.000 description 4
• 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 4
• 108010090804 Streptavidin Proteins 0.000 description 4
• 239000002168 alkylating agent Substances 0.000 description 4
• 229940100198 alkylating agent Drugs 0.000 description 4
• 230000000692 anti-sense effect Effects 0.000 description 4
• 210000004899 c-terminal region Anatomy 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 239000003638 chemical reducing agent Substances 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 230000022811 deglycosylation Effects 0.000 description 4
• 238000009795 derivation Methods 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 239000012990 dithiocarbamate Substances 0.000 description 4
• 239000012156 elution solvent Substances 0.000 description 4
• 230000005284 excitation Effects 0.000 description 4
• 235000013350 formula milk Nutrition 0.000 description 4
• 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
• 150000004676 glycans Chemical class 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• ITFSNTMIZQUALH-BYBYOKTNSA-N n-[(2r,3r,4s,5r)-6-[(2s,3s,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-bis[[(2r,3s,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydro Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@H]1O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@@H]1[C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O ITFSNTMIZQUALH-BYBYOKTNSA-N 0.000 description 4
• 229950006780 n-acetylglucosamine Drugs 0.000 description 4
• 229920001220 nitrocellulos Polymers 0.000 description 4
• 239000004800 polyvinyl chloride Substances 0.000 description 4
• 229920000915 polyvinyl chloride Polymers 0.000 description 4
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• 238000004448 titration Methods 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• SBKVPJHMSUXZTA-MEJXFZFPSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 SBKVPJHMSUXZTA-MEJXFZFPSA-N 0.000 description 3
• UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 3
• NGYHUCPPLJOZIX-XLPZGREQSA-N 5-methyl-dCTP Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NGYHUCPPLJOZIX-XLPZGREQSA-N 0.000 description 3
• 108700016155 Acyl transferases Proteins 0.000 description 3
• 102000057234 Acyl transferases Human genes 0.000 description 3
• 229920001817 Agar Polymers 0.000 description 3
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 3
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
• 108010038049 Mating Factor Proteins 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 101710144128 Non-structural protein 2 Proteins 0.000 description 3
• 101710199667 Nuclear export protein Proteins 0.000 description 3
• 241000282577 Pan troglodytes Species 0.000 description 3
• 108091093037 Peptide nucleic acid Proteins 0.000 description 3
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
• PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 3
• 102000002933 Thioredoxin Human genes 0.000 description 3
• 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 239000008272 agar Substances 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 239000012472 biological sample Substances 0.000 description 3
• 229940041514 candida albicans extract Drugs 0.000 description 3
• DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 239000006285 cell suspension Substances 0.000 description 3
• 230000036755 cellular response Effects 0.000 description 3
• 230000003196 chaotropic effect Effects 0.000 description 3
• 239000013043 chemical agent Substances 0.000 description 3
• NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 230000008021 deposition Effects 0.000 description 3
• 238000003745 diagnosis Methods 0.000 description 3
• VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 3
• 238000001962 electrophoresis Methods 0.000 description 3
• 239000012530 fluid Substances 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 210000002288 golgi apparatus Anatomy 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 230000036039 immunity Effects 0.000 description 3
• 230000005847 immunogenicity Effects 0.000 description 3
• 230000001965 increasing effect Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 229910021645 metal ion Inorganic materials 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 102000013415 peroxidase activity proteins Human genes 0.000 description 3
• 108040007629 peroxidase activity proteins Proteins 0.000 description 3
• 239000013600 plasmid vector Substances 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 230000001323 posttranslational effect Effects 0.000 description 3
• 239000002244 precipitate Substances 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000004393 prognosis Methods 0.000 description 3
• 235000019419 proteases Nutrition 0.000 description 3
• 230000006337 proteolytic cleavage Effects 0.000 description 3
• 239000012264 purified product Substances 0.000 description 3
• 230000002285 radioactive effect Effects 0.000 description 3
• 239000011535 reaction buffer Substances 0.000 description 3
• 229920006395 saturated elastomer Polymers 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• 238000012807 shake-flask culturing Methods 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000012279 sodium borohydride Substances 0.000 description 3
• 229910000033 sodium borohydride Inorganic materials 0.000 description 3
• 230000006641 stabilisation Effects 0.000 description 3
• 238000011105 stabilization Methods 0.000 description 3
• 230000000087 stabilizing effect Effects 0.000 description 3
• 239000011593 sulfur Substances 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 108060008226 thioredoxin Proteins 0.000 description 3
• 229940094937 thioredoxin Drugs 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 238000000108 ultra-filtration Methods 0.000 description 3
• 210000003501 vero cell Anatomy 0.000 description 3
• 239000012138 yeast extract Substances 0.000 description 3
• 239000007222 ypd medium Substances 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
• DRHZYJAUECRAJM-DWSYSWFDSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-[(2s,3r,4s,5r,6r)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(3s,5s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C=O)C)O)C(=O)O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@](O)(CO)CO3)O)[C@H](O)CO2)O)[C@H](C)O1)O)O)OC(=O)C[C@@H](O)C[C@H](OC(=O)C[C@@H](O)C[C@@H]([C@@H](C)CC)O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)[C@@H](C)CC)C(O)=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O DRHZYJAUECRAJM-DWSYSWFDSA-N 0.000 description 2
• VYEWZWBILJHHCU-OMQUDAQFSA-N (e)-n-[(2s,3r,4r,5r,6r)-2-[(2r,3r,4s,5s,6s)-3-acetamido-5-amino-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-5-methylhex-2-enamide Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)C(O)C[C@@H]2[C@H](O)[C@H](O)[C@H]([C@@H](O2)O[C@@H]2[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O2)NC(C)=O)NC(=O)/C=C/CC(C)C)C=CC(=O)NC1=O VYEWZWBILJHHCU-OMQUDAQFSA-N 0.000 description 2
• QFRHEHPVTSCSIH-UHFFFAOYSA-N 2,2,2-trifluoro-n-(2-iodoethyl)acetamide Chemical compound FC(F)(F)C(=O)NCCI QFRHEHPVTSCSIH-UHFFFAOYSA-N 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 108090000565 Capsid Proteins Proteins 0.000 description 2
• 241000238154 Carcinus maenas Species 0.000 description 2
• QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
• 108010087806 Carnosine Proteins 0.000 description 2
• 102000003902 Cathepsin C Human genes 0.000 description 2
• 108090000267 Cathepsin C Proteins 0.000 description 2
• 238000012286 ELISA Assay Methods 0.000 description 2
• 101100223032 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) dapB gene Proteins 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• 210000000712 G cell Anatomy 0.000 description 2
• 102000017278 Glutaredoxin Human genes 0.000 description 2
• 108050005205 Glutaredoxin Proteins 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 229940121672 Glycosylation inhibitor Drugs 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 208000032843 Hemorrhage Diseases 0.000 description 2
• 108091006054 His-tagged proteins Proteins 0.000 description 2
• 101800000120 Host translation inhibitor nsp1 Proteins 0.000 description 2
• QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
• 241000257303 Hymenoptera Species 0.000 description 2
• 108050008546 Hyperglycemic hormone Proteins 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 101150045458 KEX2 gene Proteins 0.000 description 2
• 101800000517 Leader protein Proteins 0.000 description 2
• 206010067125 Liver injury Diseases 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 108050000633 Lysozyme C Proteins 0.000 description 2
• CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
• 101800000512 Non-structural protein 1 Proteins 0.000 description 2
• 239000001888 Peptone Substances 0.000 description 2
• 108010080698 Peptones Proteins 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 101710118538 Protease Proteins 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• 101150028158 STE13 gene Proteins 0.000 description 2
• 241001123650 Schwanniomyces occidentalis Species 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• 101710172711 Structural protein Proteins 0.000 description 2
• 230000005867 T cell response Effects 0.000 description 2
• 102000005488 Thioesterase Human genes 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 108010015780 Viral Core Proteins Proteins 0.000 description 2
• 108010084455 Zeocin Proteins 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 108700014220 acyltransferase activity proteins Proteins 0.000 description 2
• 108091005588 alkylated proteins Proteins 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 108090000637 alpha-Amylases Proteins 0.000 description 2
• 102000004139 alpha-Amylases Human genes 0.000 description 2
• 229940024171 alpha-amylase Drugs 0.000 description 2
• 229940037003 alum Drugs 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 230000001745 anti-biotin effect Effects 0.000 description 2
• 239000002518 antifoaming agent Substances 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 235000009582 asparagine Nutrition 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 238000006664 bond formation reaction Methods 0.000 description 2
• 239000006227 byproduct Substances 0.000 description 2
• 229940044199 carnosine Drugs 0.000 description 2
• CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
• 230000007969 cellular immunity Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 238000011210 chromatographic step Methods 0.000 description 2
• 230000035071 co-translational protein modification Effects 0.000 description 2
• 238000009295 crossflow filtration Methods 0.000 description 2
• 239000002577 cryoprotective agent Substances 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 239000005547 deoxyribonucleotide Chemical class 0.000 description 2
• 125000002637 deoxyribonucleotide group Chemical class 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 238000004090 dissolution Methods 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 230000000367 exoproteolytic effect Effects 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000011888 foil Substances 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 102000003642 glutaminyl-peptide cyclotransferase Human genes 0.000 description 2
• 108010081484 glutaminyl-peptide cyclotransferase Proteins 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
• 231100000234 hepatic damage Toxicity 0.000 description 2
• 208000006454 hepatitis Diseases 0.000 description 2
• IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 2
• 229940006607 hirudin Drugs 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 230000009610 hypersensitivity Effects 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 239000000543 intermediate Substances 0.000 description 2
• 239000007927 intramuscular injection Substances 0.000 description 2
• 238000010255 intramuscular injection Methods 0.000 description 2
• JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 238000009630 liquid culture Methods 0.000 description 2
• 230000008818 liver damage Effects 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 230000001589 lymphoproliferative effect Effects 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
• 108010091748 peptide A Proteins 0.000 description 2
• 235000019319 peptone Nutrition 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 2
• CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 229940021993 prophylactic vaccine Drugs 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 235000021251 pulses Nutrition 0.000 description 2
• 239000013014 purified material Substances 0.000 description 2
• 239000008213 purified water Substances 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical class 0.000 description 2
• 238000011218 seed culture Methods 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 235000010265 sodium sulphite Nutrition 0.000 description 2
• 238000005063 solubilization Methods 0.000 description 2
• 230000007928 solubilization Effects 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 108020002982 thioesterase Proteins 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 2
• YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
• JCUXTOGGBVGVNH-UHFFFAOYSA-N 1-[amino-(4-aminophenyl)arsanyl]hexan-1-one Chemical compound CCCCCC(=O)[As](N)C1=CC=C(N)C=C1 JCUXTOGGBVGVNH-UHFFFAOYSA-N 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
• YWXCBLUCVBSYNJ-UHFFFAOYSA-N 2-(2-sulfanylethylsulfonyl)ethanethiol Chemical compound SCCS(=O)(=O)CCS YWXCBLUCVBSYNJ-UHFFFAOYSA-N 0.000 description 1
• WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
• IZQAUUVBKYXMET-UHFFFAOYSA-N 2-bromoethanamine Chemical compound NCCBr IZQAUUVBKYXMET-UHFFFAOYSA-N 0.000 description 1
• KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
• CYWHLOXWVAWMFO-UHFFFAOYSA-N 3-sulfanyl-1h-pyridine-2-thione Chemical compound SC1=CC=CN=C1S CYWHLOXWVAWMFO-UHFFFAOYSA-N 0.000 description 1
• 108010011619 6-Phytase Proteins 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 208000030090 Acute Disease Diseases 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108700023418 Amidases Proteins 0.000 description 1
• 102000004400 Aminopeptidases Human genes 0.000 description 1
• 108090000915 Aminopeptidases Proteins 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 108010065511 Amylases Proteins 0.000 description 1
• 102000013142 Amylases Human genes 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 108010002913 Asialoglycoproteins Proteins 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241000228245 Aspergillus niger Species 0.000 description 1
• 241000228251 Aspergillus phoenicis Species 0.000 description 1
• 108020000946 Bacterial DNA Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 230000005653 Brownian motion process Effects 0.000 description 1
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• QOFRNSMLZCPQKL-KTIIIUPTSA-N CCN(CC)CC.CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)NCCO[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC Chemical compound CCN(CC)CC.CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)NCCO[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC QOFRNSMLZCPQKL-KTIIIUPTSA-N 0.000 description 1
• 101100176198 Caenorhabditis elegans nst-1 gene Proteins 0.000 description 1
• 241000178270 Canarypox virus Species 0.000 description 1
• 101001007681 Candida albicans (strain WO-1) Kexin Proteins 0.000 description 1
• 108010039939 Cell Wall Skeleton Proteins 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 206010008909 Chronic Hepatitis Diseases 0.000 description 1
• 206010011469 Crying Diseases 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
• 239000003298 DNA probe Substances 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 102100031636 Dynein axonemal heavy chain 9 Human genes 0.000 description 1
• 241000589566 Elizabethkingia meningoseptica Species 0.000 description 1
• 101710121417 Envelope glycoprotein Proteins 0.000 description 1
• 101710204837 Envelope small membrane protein Proteins 0.000 description 1
• 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
• 241001131785 Escherichia coli HB101 Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 108010091443 Exopeptidases Proteins 0.000 description 1
• 102000018389 Exopeptidases Human genes 0.000 description 1
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 229910004373 HOAc Inorganic materials 0.000 description 1
• 101000575170 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) 50S ribosomal protein L12 Proteins 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102000007625 Hirudins Human genes 0.000 description 1
• 108010007267 Hirudins Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000866325 Homo sapiens Dynein axonemal heavy chain 9 Proteins 0.000 description 1
• 101000957351 Homo sapiens Myc-associated zinc finger protein Proteins 0.000 description 1
• 101000716996 Homo sapiens Suppressor APC domain-containing protein 1 Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 229920001202 Inulin Polymers 0.000 description 1
• 241000235649 Kluyveromyces Species 0.000 description 1
• 241001138401 Kluyveromyces lactis Species 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
• 241000235087 Lachancea kluyveri Species 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
• 102000008791 Lysozyme C Human genes 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 241001183012 Modified Vaccinia Ankara virus Species 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 102100038750 Myc-associated zinc finger protein Human genes 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 241000221961 Neurospora crassa Species 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 241000551283 Ogataea polymorpha RB11 Species 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 238000001069 Raman spectroscopy Methods 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 101710088839 Replication initiation protein Proteins 0.000 description 1
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
• 235000011449 Rosa Nutrition 0.000 description 1
• 241000582914 Saccharomyces uvarum Species 0.000 description 1
• 241000235346 Schizosaccharomyces Species 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 241000311088 Schwanniomyces Species 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 102100020924 Suppressor APC domain-containing protein 1 Human genes 0.000 description 1
• BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
• 229920004898 Triton X-705 Polymers 0.000 description 1
• LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 102000035181 adaptor proteins Human genes 0.000 description 1
• 108091005764 adaptor proteins Proteins 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 230000002776 aggregation Effects 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 230000002009 allergenic effect Effects 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• 102000005840 alpha-Galactosidase Human genes 0.000 description 1
• 108010030291 alpha-Galactosidase Proteins 0.000 description 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
• 102000005922 amidase Human genes 0.000 description 1
• 235000019418 amylase Nutrition 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 230000003078 antioxidant effect Effects 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 238000000149 argon plasma sintering Methods 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000005311 autocorrelation function Methods 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• DKXNBNKWCZZMJT-VOXHDCLVSA-N beta-D-glucosyl-(1->4)-aldehydo-D-mannose Chemical compound O=C[C@@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DKXNBNKWCZZMJT-VOXHDCLVSA-N 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• 102000005936 beta-Galactosidase Human genes 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 238000005537 brownian motion Methods 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 239000012018 catalyst precursor Substances 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 210000004520 cell wall skeleton Anatomy 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• 238000011097 chromatography purification Methods 0.000 description 1
• 239000012539 chromatography resin Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000001427 coherent effect Effects 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 230000008094 contradictory effect Effects 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 238000012136 culture method Methods 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 229960002433 cysteine Drugs 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 230000004665 defense response Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 238000011033 desalting Methods 0.000 description 1
• 230000006326 desulfonation Effects 0.000 description 1
• 238000005869 desulfonation reaction Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• VLYUGYAKYZETRF-UHFFFAOYSA-N dihydrolipoamide Chemical compound NC(=O)CCCCC(S)CCS VLYUGYAKYZETRF-UHFFFAOYSA-N 0.000 description 1
• 239000013024 dilution buffer Substances 0.000 description 1
• XIMIGUBYDJDCKI-UHFFFAOYSA-N diselenium Chemical compound [Se]=[Se] XIMIGUBYDJDCKI-UHFFFAOYSA-N 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• 150000004659 dithiocarbamates Chemical class 0.000 description 1
• 150000004662 dithiols Chemical class 0.000 description 1
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000003241 endoproteolytic effect Effects 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 239000012520 frozen sample Substances 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 238000003205 genotyping method Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000006481 glucose medium Substances 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 230000001279 glycosylating effect Effects 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 150000002431 hydrogen Chemical class 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
• 230000037451 immune surveillance Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000004957 immunoregulator effect Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229940029339 inulin Drugs 0.000 description 1
• JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 238000012317 liver biopsy Methods 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
• LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
• 210000005075 mammary gland Anatomy 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 230000000873 masking effect Effects 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 239000007923 nasal drop Substances 0.000 description 1
• 229940100662 nasal drops Drugs 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 229940097496 nasal spray Drugs 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 238000006384 oligomerization reaction Methods 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 229940085127 phytase Drugs 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229920001308 poly(aminoacid) Polymers 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000011533 pre-incubation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 229940043274 prophylactic drug Drugs 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006697 redox regulation Effects 0.000 description 1
• 239000013074 reference sample Substances 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 229960000329 ribavirin Drugs 0.000 description 1
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 235000017709 saponins Nutrition 0.000 description 1
• 150000003958 selenols Chemical class 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 239000012798 spherical particle Substances 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 229940031439 squalene Drugs 0.000 description 1
• TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 108010087967 type I signal peptidase Proteins 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1